Parkman Healthcare Partners LLC Alnylam Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 25,485 shares of ALNY stock, worth $6.26 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

25,485

Holding current value

$6.26 Million

% of portfolio

0.99%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $5.96 Million - $7.31 Million	25,485 New	25,485 $7.01 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $1.37 Million - $2.29 Million	-9,861 Reduced 47.56%	10,873 $2.18 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $4.01 Million - $5.63 Million	-33,274 Reduced 61.61%	20,734 $3.02 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $467,259 - $638,945	-3,674 Reduced 6.37%	54,008 $8.82 Million
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $2.76 Million - $3.62 Million	-17,285 Reduced 23.06%	57,682 $9.78 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $1.28 Million - $1.76 Million	9,924 Added 15.26%	74,967 $12.7 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $3.66 Million - $5.07 Million	28,882 Added 79.87%	65,043 $9.18 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $651,495 - $778,806	5,298 Added 17.17%	36,161 $4.7 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $605,950 - $827,450	-5,000 Reduced 13.94%	30,863 $4.49 Million
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $52,105 - $78,220	-500 Reduced 1.38%	35,863 $5.31 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $126,922 - $182,628	1,363 Added 3.89%	36,363 $3.96 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $2.61 Million - $4.35 Million	35,000 New	35,000 $4.03 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Alnylam Pharmaceuticals, Inc. Transaction History